Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 290858011000036117 | amprenavir 150 mg capsule (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 290859011000036113 | amprenavir 150 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| amprenavir 150 mg capsule | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| amprenavir 150 mg capsule | Is a | amprenavir | true | Inferred relationship | Some | ||
| amprenavir 150 mg capsule | has intended active ingredient | amprenavir | true | Inferred relationship | Some | 1789729872 | |
| amprenavir 150 mg capsule | has Australian BoSS | amprenavir | true | Inferred relationship | Some | 1789729872 | |
| amprenavir 150 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| amprenavir 150 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 1789729873 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Agenerase 150 mg capsule | Is a | True | amprenavir 150 mg capsule | Inferred relationship | Some | |
| amprenavir 150 mg capsule, 240 | has MPUU | True | amprenavir 150 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR